MSP Recovery (MSPR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
14 Aug, 2025Executive summary
Reported a net loss of $241.8 million for Q2 2025 and $477.8 million for the six months ended June 30, 2025, reflecting continued substantial losses year-over-year.
Revenue for Q2 2025 was $0.5 million, up 59% from Q2 2024, but six-month revenue fell 78% year-over-year to $1.4 million.
Operating expenses remain high, with claims amortization expense of $118.6 million in Q2 and $237.3 million for the six months, and interest expense rising sharply to $124.7 million in Q2.
The company continues to face significant liquidity challenges, with only $4.0 million in unrestricted cash as of June 30, 2025, and substantial doubt about its ability to continue as a going concern.
The Yorkville SEPA is currently the sole source of liquidity, and the company may be forced to seek bankruptcy protection if additional funding is not secured.
Financial highlights
Q2 2025 net loss attributable to the company was $143.2 million; six-month net loss attributable to the company was $264.8 million.
Revenue for Q2 2025 was $0.5 million, up from $0.3 million in Q2 2024; six-month revenue was $1.4 million, down from $6.3 million year-over-year.
Operating loss for Q2 2025 was $124.8 million, an 8% improvement from Q2 2024; six-month operating loss was $251.8 million, a 5% improvement year-over-year.
Interest expense increased to $124.7 million in Q2 2025, up 22% from Q2 2024; six-month interest expense was $243.5 million, up 22% year-over-year.
Cash used in operations for the six months ended June 30, 2025 was $15.7 million, up from $11.2 million in the prior year period.
Outlook and guidance
Management has concluded that current plans are insufficient to alleviate substantial doubt about the company's ability to continue as a going concern.
The company is seeking additional funding but has no assurance of success; if Yorkville SEPA funding is unavailable, insolvency or bankruptcy may be required.
No formal revenue or earnings guidance provided; future performance is highly dependent on successful claim recoveries and new funding.
Latest events from MSP Recovery
- Annual meeting to vote on director re-election and auditor ratification, with strong governance.MSPR
Proxy Filing2 Dec 2025 - Approval sought for reverse stock split and major share issuance to support Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Key votes on a reverse stock split and major share issuance to VRM to ensure Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Vote on reverse split and VRM share issuance may reshape ownership and Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Shareholders are advised to await a corrected proxy statement with updated meeting details.MSPR
Proxy Filing2 Dec 2025 - Registering nearly 10M shares for resale amid high losses, debt, and going concern risks.MSPR
Registration Filing29 Nov 2025 - Registration covers nearly 10 million shares for resale, including warrant and service-related issuances.MSPR
Registration Filing29 Nov 2025 - Healthcare claims recovery firm registers 8.4M shares for resale amid ongoing losses and high debt.MSPR
Registration Filing29 Nov 2025 - Severe revenue decline, mounting losses, and delisting risk threaten ongoing operations.MSPR
Q3 202519 Nov 2025